Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate which anti-inflammatory treatment is best at preventing postoperative inflammation following cataract surgery. We want to compare topical prophylaxis with NSAID eye drops to topical prophylaxis with a combination of NSAID and prednisolone. We also want to compare topical prophylaxis with eye drops to drop-less surgery where the anti-inflammatory drug is administered to the subtenonal space at the conclusion of the surgical procedure. In addition, we want to investigate if topical anti-inflammatory prophylaxis should be initiated preoperatively or postoperatively. The primary outcome is change in central macular thickness, measured by optical coherence tomography, 3 months after surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03383328
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase Phase 4
Start date February 1, 2018
Completion date December 18, 2019

See also
  Status Clinical Trial Phase
Completed NCT03404323 - "Cataract Surgery in Eyes With Epiretinal Membrane" N/A
Terminated NCT03396861 - Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept Phase 1
Recruiting NCT05337332 - Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Phase 2/Phase 3